Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
10/2003
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082826A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003005959A3 Amphiphilic star-like macromolecules for drug delivery
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191342 Process for the production of crystals of a benzoic acid derivative
10/09/2003US20030191341 Chemical process
10/09/2003US20030191322 Synthetic pathway from reacting chemical intermediates 4-carboxy oxazoline with a formyl amide, decarboxylation, hydroxylation, decyclization, lactamization, saponification; proteasome inhibitors, antiinflammatory, antitumor agents
10/09/2003US20030191217 Amorphous or liquid phenolic compounds having a carboxy group as stabilizers for processing molding plastics are controllably, uniformly dispersed and reproducible; nondiffusing; no bleeding-out; no surface deposits
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191027 Herbicides
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2479928A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349453A2 Biocide compositions and methods and systems employing same
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447788A Process for prodn. of calcium pantothenate
10/08/2003CN1446795A Method for synthesizing N-salicyloyl-8-sodium aminocaprylic acid
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/02/2003WO2002018303A3 Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
10/02/2003US20030187301 Amidation, acetylation, reduction, ethylation, salt formation; chemical intermediate for the synthesis of beta 2-adrenoceptor agonist, treating asthma and chronic obstructive pulmonary disorder
10/02/2003US20030187068 Substituted phenylpropionic acid derivatives
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030186944 Novel aromatic compounds
10/01/2003EP1347960A1 Process for preparing ( ) trans-4-p-fluorophenyl-3-hydroxymethyl-1
10/01/2003EP1206187B1 High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003EP0960095B1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
10/01/2003CN1445211A New amide ramification of sweetsop as well as its preparing method, its medication composition and usage
10/01/2003CN1122659C Synthesis preparation method of high-effective hemostatic notoginseng extract
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627763 Compounds having protected hydroxy groups
09/30/2003CA2103167C Compositions and methods for inhibiting browning in foods and beverages
09/25/2003WO2003078382A1 N-biphenylamides and fungicidal compositions containing the same
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2002100818A3 Aminediols as agents for the treatment of alzheimer's disease
09/25/2003US20030181765 Reacting an azide compound with an amine to form an intermediate, reducting the azide of the intermediate to form amine; amidation, reduction of azide, azidation, blocking hydroxy group, lactonization and deblocking
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/24/2003EP1345884A1 Anti-viral compounds
09/24/2003EP1002793B1 Physiologically active substances tkr2449, process for producing the same, and microorganism
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624196 Particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment of multiple sclerosis, cardiovascular disorders
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/23/2003CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
09/23/2003CA2084041C Diphenyl acetic acid derivatives
09/18/2003WO2003076392A2 Z-substituted acrylamides, methods for production thereof and agents comprising the same
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003WO2003076387A2 Process for preparing 2-aminoindan derivatives
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003US20030176506 For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030175742 Comprises pyrene, perylene, coronene, and/or rubrene groups; solid phase synthesis; for DNA analysis; fluorescent in situ hybridization (FISH)
09/18/2003CA2477949A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1119529B1 Chemical constructs
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620963 TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-PHENYL AND TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-HETEROARYL AND RELATED COMPOUNDS HAVING RARα RECEPTOR SELECTIVE BIOLOGICAL ACTIVITY
09/16/2003CA2105683C N-¬¬4,5-dihydroxy-and 4,5,8-trihydroxy-9,10-dihydro-9, 10-dioxo-2-anthracene-yl|carbonyl|amino acids useful in the therapy of osteoarticular affections
09/12/2003WO2003074471A1 Haloacetamide and azide substituted compounds and methods of use thereof
09/12/2003WO2002002684A9 Stabilisers, in particular for thermoplastic polyurethanes
09/12/2003CA2476657A1 Haloacetamide and azide substituted compounds and methods of use thereof
09/11/2003WO2003074449A2 Multi-substitued selective androgen receptor modulators and methods of use thereof
09/11/2003US20030171617 E.g., 2-(3,4-Dihydroxyphenyl)-N-n-hexyl-2-hydroxyacetamide; antioxidants and/or free-radical scavengers for cosmetics and foods
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171409 Novel delta dicarbonyl compounds and methods for using the same
09/11/2003US20030171339 Novel retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1341784A2 Process for making a thrombin inhibitor
09/10/2003EP1341745A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage
09/10/2003EP1341743A2 Organic reactions with co generating materials
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003EP0783299B1 Compounds and compositions for delivering active agents
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/10/2003CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists
09/04/2003WO2003072540A1 Novel pseudoceramides and cosmetic compositions comprising the same
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166693 Benzene derivatives and pharmaceutical use thereof
09/04/2003US20030166691 Phenylalanine derivatives
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166487 Normally liquid, omega-hydrofluoroalkyl ether compounds (and selected mixtures thereof) have a saturated perfluoroaliphatic chain of carbon atoms interrupted by one or more ether oxygen atoms. The compounds can be prepared, by decarboxylation of
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 157